Andrela™ Compounded Testosterone Cypionate Injection USP- FOR SUBCUTANEOUS USE ONLY

Andrela™ is a 503B compounded testosterone cypionate microdosed injection, and supplied as a ready-to-use prefilled subcutaneous syringe. Each carton contains four single-dose glass syringes in a medium-chain triglyceride (MCT) oil base, which is thinner and better tolerated than the grapeseed or cottonseed oils used in many other compounded testosterone products. Andrela is manufactured in an FDA-registered, cGMP outsourcing facility on a fully automated isolator line, the same quality standard used by generic pharmaceutical manufacturers, and is available across eight strengths so your provider can titrate your dose without manual drawing, dilution, or custom compounding.

Each syringe arrives sterile, pre-measured, and ready for use after a simple priming step, eliminating the measurement errors that come with self-drawing from a multi-dose vial. Andrela is injected subcutaneously rather than intramuscularly, which most patients find more comfortable and easier to self-administer, with more stable absorption over time. Your prescriber will determine your starting strength and may adjust your dose over time based on your response and hormone levels, so check in regularly about whether your current strength remains right for you. Because the product is shelf-stable at room temperature, it travels easily and is to be stored at room temperature. Each carton carries a 12-month beyond-use date from the date of compounding, well beyond the roughly 28-day BUD typical of standard 503A compounded testosterone preparations.